Enteric methane formation in ruminants is one of the major contributors to 25 climate change. We have reported that supplementation of naturally produced 26 lovastatin reduced methane emissions in goats without adversely affecting 27 rumen fermentation and animal performance, except that at higher level, 28 lovastatin can have a negative effect on the palatability of the formulated diet. 29 As statins are associated with the development of muscle-related adverse 30 effects at higher than recommended therapeutic doses, this study was 31 conducted to examine the effects of lovastatin on the histology and proteome 32 profile of goat skeletal muscle. A total of 20 intact male Saanen goats were 33 randomly assigned in equal numbers to 4 groups, and fed with a total mixed 34 ration containing 50% rice straw, 22.8% concentrates and 27.2% of various 35 proportions of untreated or treated palm kernel cake (PKC) to achieve the target 36 daily intake levels of 0 (Control), 2 (Low), 4 (Medium) or 6 (High) mg 37 lovastatin/kg body weight (BW). Histological examination discovered that the 38 longissimus thoracis et lumborum muscle of animals from the Medium and High 39 treatment groups showed abnormalities in terms of necrosis, degeneration, 40 interstitial space and vacuolation. Western blot analysis conducted on the 41 myosin heavy chain showed that the immunoreactivity of myosin heavy chain in 42 the High treatment group was significantly lower than the Control, Low and 43 Medium treatment groups. Comparisons between control and lovastatin-treated 44 groups demonstrated that lovastatin supplementation induced complex 45 modifications to the protein expression patterns of the longissimus thoracis et 46 lumborum muscle of the goat. There were 30, 26 and 24 proteins differentially 47 expressed in Low, Medium and High treatment groups respectively, when 3 48 compared to the Control group. Supplementation of lovastatin down-regulated 49 proteins involved in carbohydrate and creatine metabolism, indicative of 50 reduced energy production, and may have contributed to the skeletal muscle 51 damage. Supplementation of naturally produced lovastatin induced muscle 52 damage in longissimus thoracis et lumborum muscle of goats with increasing 53 dosages, particularly at 6mg/kg BW. In addition, proteomics analysis revealed 54 that lovastatin supplementation induced complex modifications to the protein 55 expressions of skeletal muscle of goats which may have contributed to the 56 observed skeletal muscle damage. Present study suggested that 57 supplementation of naturally-produced lovastatin at 6mg/kg BW could adversely 58 affecting health and wellbeing of the animals. 59 60 65 methane formation results from the activity of complex interactions of anaerobic 66 bacteria which together enable degradation of ruminant feeds and 67 methanogenic archaea which help remove metabolic hydrogen in the rumen [3]. 68 Despite the importance of methanogenesis in maintaining low partial pressure 69 of hydrogen required for efficient ruminal fermentation, the formation of 70 methane also represents 2-12% loss of gross dietary energy [4]. Hence, 71 extensive research efforts are focused on the development of strategies to 4 72 modify ruminal fermentation for reduction of methane emissions [5] as well as 73 better feed utilization [6]. 74 75 Among the potential strategies for mitigating methane emissions, 76 supplementation of feed additives such as ionophores [7], organic acids [8], 77 fatty acids [9], methyl coenzyme M reductase inhibitors [10], vaccine [11] and 78 oils [12] have been extensively researched. However, many of these strategies 79 have limited application due to their negative effect(s) on human and animal 80 health, animal performance parameters and economical acceptance [13]. 81 Supplementation of naturally produced lovastatin is a promising approach for 82 mitigating methane emissions. 83 84 Lovastatin (C24H36O5, M.W. 404.55) is a secondary product during the 85 secondary phase (idiophase) of fungal growth. It is a competitive inhibitor of 3-86 hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, which is a key 87 enzyme in the cholesterol production pathway [14]. Inhibition of HMG-CoA 88 reductase will mediate the suppression of cholesterol synthesis and cell 89 membrane formation in methanogenic Archaea. A previous study has shown 90 that significant reduction in growth and activity of methanogenic Archaea using 91 lovastatin without any negative effect on cellulolytic bacteria [15]. In addition, 92 naturally produced lovastatin has been shown to mitigate methane gas 93 emissions, while simultaneously enhancing digestibility of feed [16].
Introduction 61
Methane gas is one of the major greenhouse gases that is contributing to 62 climate change. Livestock production has been reported to contribute 63 approximately 18% of methane emissions and 9% of carbon dioxide production 64 [1], which results primarily from the enteric fermentation of feeds [2] . Enteric
The muscle tissues were evaluated for evidence of necrosis, degeneration, 145 interstitial space and vacuolization. Numerical scores were assigned based on 146 degree of severity (0 = normal to 5 = severe) according to Gall et al. [19] (Table   147 1). Histological scores between every treatment groups were compared using 148 Kruskal-Wallis test. Statistical confidence was considered as P<0.05. Immunoblot analysis of myofibrillar proteins 155 All muscle samples were pulverized into powder form with pestle and mortar 
Control, Low, Medium and High represent 0, 2, 4 and 6 mg lovastatin/kg BW, respectively.
289
Data was presented as the median, minimum and maximum of the score. Expressions of myosin heavy chain and actin 294 The difference in the immunoreactivities of myosin heavy chain and actin of 295 longissimus thoracis et lumborum muscle in the goats supplemented with 296 various lovastatin levels is presented in Table 3 . There were significant 297 differences in the expression of myosin heavy chain between the treatment 298 groups, while the expression of actin was found to be unaffected by lovastatin observed to be down-regulated and five proteins up-regulated (Table 5 ). When 333 the Control and High treatment groups were compared, 23 proteins were down-334 regulated and one protein was up-regulated in the muscle tissue (Table 6) . The differentially expressed proteins were subjected to IPA® analysis.
412
These proteins were identified to be associated with several possible canonical 413 pathways, which including glycolysis I, gluconeogenesis I, glucose and glucose-414 1-phosphate degradation, creatine-phosphate biosynthesis and pyruvate 415 fermentation to lactate. Generally, these proteins were involved in a network of 416 carbohydrate metabolism, energy production, and skeletal and muscular system 417 development and function. cramps and/or stiffness on skeletal muscles in humans [24] . We had previously 424 reported that lovastatin effectively decreased methane production in goats [18] .
425
Given the potential for myopathies at higher than recommended therapeutic 426 doses the effects of naturally produced statins on the skeletal muscles of Carbohydrate metabolism 480 The present study showed that lovastatin supplementation down- subsequently the reduction in ATP production. 
554
Interestingly, previous study showed that the transgenic mice lacking either the 555 cytoplasmic or mitochondrial creatine kinase may develop muscle atrophy [38] .
556
Together with proteins involved in carbohydrate metabolism, down-regulation of 557 creatine kinase indicated an impairment to the energy production system, which 558 may develop statin myopathy. Usually, a large amount of lactate is generated in proliferating cells to allow high
